康辰药业(603590.SH)发布前三季度业绩，归母净利润1.28亿元，同比增长13.19%

Core Insights - 康辰药业 reported a revenue of 692 million yuan for the first three quarters of 2025, representing a year-on-year growth of 7.10% [1] - The company's net profit attributable to shareholders reached 128 million yuan, showing a year-on-year increase of 13.19% [1] - The non-recurring net profit was 133 million yuan, reflecting a year-on-year growth of 25.90% [1] - Basic earnings per share stood at 0.81 yuan [1]